Moreover, blocking immunosuppressive molecules (TGF-β, IL-10) expressed either by cancer cells or by tumor-infiltrating immune cells [267] could represent another therapeutic strategy for the treatment of TC. The gene discussed is TGFB1; the disease is cancer.